Skip to main content
Log in

Nitric oxide/cGMP signalling mediates the cardioprotective action of adrenomedullin in reperfused myocardium

  • Original Contribution
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Abstract

We demonstrated previously that adrenomedullin (AM), when given during early reperfusion, limited infarct size in rat heart. The present study was undertaken to provide direct evidence of the NO-dependency of AM’s cardioprotective action by assessing NO biosynthesis and involvement of the soluble guanylyl cyclase (sGC) pathway. Perfused hearts from male CD-1 mice were subjected to 30-min left coronary occlusion and 60-min reperfusion. Infarct size was determined by tetrazolium staining. AM 10 nM was administered from 20 min after coronary occlusion until 10 min after reperfusion. Coronary effluent was analysed for NO2 and NO3 , and myocardial samples were analysed for NO2 , NO3 , nitroso-adducts and cGMP concentration. To examine the role of NO/sGC signalling in the infarct-limiting action of AM, further hearts received the sGC inhibitor ODQ 2 μM. AM treatment stimulated NO synthesis, indicated by increased NO2 efflux in coronary effluent throughout reperfusion (summarised as area under curve, AM 29.2 ± 3.9 vs. control 14.4 ± 2.8 μmol min2 mL−1, P < 0.05). AM limited infarct size (35.4 ± 2.7 vs. 12.2 ± 2.3%, P < 0.01), associated with a 2.45-fold increase (P < 0.05) in myocardial cGMP concentration at 10 min after reperfusion. ODQ abolished the infarct size-limiting effect of AM (28.9 ± 4.3%). These data provide the first evidence that AM increases NO bioavailability in intact murine myocardium and confirm that the NO/sGC/cGMP pathway is central to the cytoprotective action of AM against ischaemia–reperfusion injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

AM:

Adrenomedullin

cGMP:

Guanosine-3′, 5′-cyclic monophosphate

mPTP:

Mitochondrial permeability transition pore

NO:

Nitric oxide

NO2 :

Nitrite

NO3 :

Nitrate

NOS:

Nitric oxide synthase

ODQ:

1H[1,2,4]oxodiazole-[4,3-a]-quinoxalin-1-one

PI3K:

Phosphoinositol-3-kinase

PKG:

Protein kinase G

RXNOs:

Total nitros(yl)ated chemical species

sGC:

Soluble guanylyl cyclase

References

  1. Abdallah Y, Gkatzoflia A, Pieper H, Zoga E, Walther S, Kasseckert S, Schäfer M, Schlüter KD, Piper HM, Schäfer C (2005) Mechanism of cGMP-mediated protection in a cellular model of myocardial reperfusion injury. Cardiovasc Res 66:123–131

    Article  CAS  PubMed  Google Scholar 

  2. Burley DS, Baxter GF (2007) B-type natriuretic peptide at reperfusion limits infarct size in rat isolated heart. Basic Res Cardiol 102:529–541

    Article  CAS  PubMed  Google Scholar 

  3. Burley DS, Ferdinandy P, Baxter GF (2007) Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signalling. Br J Pharmacol 152:855–869

    Article  CAS  PubMed  Google Scholar 

  4. Burley DS, Hamid SA, Baxter GF (2007) Cardioprotective actions of peptide hormones in myocardial ischemia. Heart Fail Rev 12:279–291

    Article  CAS  PubMed  Google Scholar 

  5. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO 3rd, Gladwin MT (2003) Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9:1498–1505

    Article  CAS  PubMed  Google Scholar 

  6. Costa AD, Garlid KD, West IC, Lincoln TM, Downey JM, Cohen MV, Critz SD (2005) Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 97:329–346

    Article  CAS  PubMed  Google Scholar 

  7. Csonka C, Szilvássy Z, Fülöp F, Páli T, Blasig IE, Tosaki A, Schulz R, Ferdinandy P (1999) Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. Circulation 100:2260–2266

    CAS  PubMed  Google Scholar 

  8. Duranski MR, Eldrod JW, Calvert JW, Bryan NS, Feelisch M, Lefer DJ (2006) Genetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 291:H2980–H2986

    Article  CAS  PubMed  Google Scholar 

  9. Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang X, Kevil CG, Gladwin MT, Lefer DJ (2005) Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 115:1232–1240

    CAS  PubMed  Google Scholar 

  10. Ferdinandy P, Schulz R, Baxter GF (2007) Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning and postconditioning. Pharmacol Rev 59:418–458

    Article  CAS  PubMed  Google Scholar 

  11. Frantz S, Adamek A, Fraccarollo D, Tillmanns J, Widder JD, Dienesch C, Schäfer A, Podolskaya A, Held M, Ruetten H, Ertl G, Bauersachs J (2009) The eNOS enhancer AVE9488: a novel cardioprotectant protectant against ischemia reperfusion injury. Basic Res Cardiol [E-pub ahead of print, 23 Jun 2009]

  12. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B (1995) Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1, 2, 4]oxadiazolo[4, 3-a]quioxalin-1-one. Mol Pharmacol 48:184–188

    CAS  PubMed  Google Scholar 

  13. Gross ER, Gross GJ (2006) Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res 70:212–221

    Article  CAS  PubMed  Google Scholar 

  14. Halestrap AP, Clarke SJ, Javadov SA (2004) Mitochondrial permeability transition pore opening during myocardial reperfusion—a target for cardioprotection. Cardiovasc Res 61:372–385

    Article  CAS  PubMed  Google Scholar 

  15. Hamid SA, Baxter GF (2005) Adrenomedullin: regulator of systemic and cardiac homeostasis in acute myocardial infarction. Pharmacol Ther 105:95–112

    Article  CAS  PubMed  Google Scholar 

  16. Hamid SA, Baxter GF (2005) Adrenomedullin limits reperfusion injury in experimental myocardial infarction. Basic Res Cardiol 100:387–396

    Article  CAS  PubMed  Google Scholar 

  17. Hamid SA, Baxter GF (2006) A critical cytoprotective role of endogenous adrenomedullin in acute myocardial infarction. J Mol Cell Cardiol 41:360–363

    Article  CAS  PubMed  Google Scholar 

  18. Hausenloy DJ, Ong SB, Yellon DM (2009) The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 104:189–202

    Article  CAS  PubMed  Google Scholar 

  19. Hausenloy DJ, Yellon DM (2007) Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 12:217–234

    Article  CAS  PubMed  Google Scholar 

  20. Heusch G, Boengler K, Schulz R (2008) Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 118:1915–1919

    Article  PubMed  Google Scholar 

  21. Ikeda U, Kanbe T, Kawahara Y, Yokoyama M, Shimada K (1996) Adrenomedullin augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. Circulation 94:2560–2565

    CAS  PubMed  Google Scholar 

  22. Ikenouchi H, Kangawa K, Matsuo H, Hirata Y (1997) Negative inotropic effect of adrenomedullin in isolated adult rabbit cardiac ventricular myocytes. Circulation 95:2318–2324

    CAS  PubMed  Google Scholar 

  23. Ishimitsu T, Ono H, Minami J, Matsuoka H (2006) Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders. Pharmacol Ther 111:909–927

    Article  CAS  PubMed  Google Scholar 

  24. Ishizaka Y, Ishizaka Y, Tanaka M, Kitamura K, Kangawa K, Minamino N, Matsuo H, Eto T (1994) Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 200:542–546

    Article  Google Scholar 

  25. Jones SP, Bolli R (2006) The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40:16–23

    Article  CAS  PubMed  Google Scholar 

  26. Kato K, Yin H, Agata J, Yoshida H, Chao L, Chao J (2003) Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am J Physiol Heart Circ Physiol 285:H1506–H1514

    CAS  PubMed  Google Scholar 

  27. Kehmeier ES, Kropp M, Kleinbongard P, Lauer T, Balzer J, Merx MW, Heusch G, Kelm M, Lepper W, Rassaf T (2008) Serial measurements of whole blood nitrite in an intensive care setting. Free Radical Biol Med 44:1945–1950

    Article  CAS  Google Scholar 

  28. Khan SQ, O’Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies J, Bergmann A, Ng LL (2007) Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 49:1525–1532

    Article  CAS  PubMed  Google Scholar 

  29. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheocromocytoma. Biochem Biophys Res Commun 192:553–560

    Article  CAS  PubMed  Google Scholar 

  30. Kuno A, Kuno A, Solenkova NV, Solodushko V, Dost T, Liu Y, Yang XM, Cohen MV, Downey JM (2008) Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C. Am J Physiol Heart Circ Physiol 295:H1288–H1295

    Article  CAS  PubMed  Google Scholar 

  31. Looi Y, Kane KA, McPhaden AR, Wainwright CL (2006) Adrenomedullin acts via nitric oxide and peroxynitrite to protect against myocardial ischemia-induced arrhythmias in anaesthetized rats. Br J Pharmacol 148:599–609

    Article  CAS  PubMed  Google Scholar 

  32. Lundberg JO, Weizberg E (2005) NO generation from nitrite and its role in vascular control. Arterioscler Thromb Vasc Biol 25:915–922

    Article  CAS  PubMed  Google Scholar 

  33. Martin C, Schulz R, Post H, Boengler K, Kelm M, Kleinbongard P, Gres P, Skyschally A, Konietzka I, Heusch G (2007) Microdialysis-based analysis of interstitial NO in situ: NO synthase-independent NO formation during myocardial ischemia. Cardiovasc Res 74:46–55

    Article  CAS  PubMed  Google Scholar 

  34. Nakamura R, Kato J, Kitamura K, Onitsuka H, Imamura T, Cao Y, Marutsuka K, Asada Y, Kangawa K, Eto T (2004) Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats. Circulation 110:426–431

    Article  CAS  PubMed  Google Scholar 

  35. Nishikimi T, Horio T, Yoshihara F, Nagaya N, Matsuo H, Kangawa K (1998) Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes. Eur J Pharmacol 353:337–344

    Article  CAS  PubMed  Google Scholar 

  36. Okumura H, Nagaya N, Itoh T, Okano I, Hino J, Mori K, Tsukamoto Y, Ishibashi-Ueda H, Miwa S, Tambara K, Toyokuni S, Yutani C, Kangawa K (2004) Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation 109:242–248

    Article  CAS  PubMed  Google Scholar 

  37. Penna C, Cappello S, Mancardi D, Raimondo S, Rastaldo R, Gattullo D, Losano G, Pagliaro P (2006) Post-conditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway. Basic Res Cardiol 101:168–179

    Google Scholar 

  38. Rassaf T, Bryan NS, Kelm M, Feelisch M (2002) Concomitant presence of N-nitroso and S-nitroso proteins in human plasma. Free Radic Biol Med 33:1590–1596

    Article  CAS  PubMed  Google Scholar 

  39. Rassaf T, Bryan NS, Maloney RE, Specian V, Kelm M, Kalyanaraman B, Rodriguez J, Feelisch M (2003) NO adducts in mammalian red blood cells: too much or too little? Nat Med 9:481–482

    Article  CAS  PubMed  Google Scholar 

  40. Rassaf T, Flogel U, Drexhage C, Hendgen-Cotta U, Kelm M, Schrader J (2007) Nitrite reductase function of deoxymyoglobin: oxygen sensor and regulator of cardiac energetics and function. Circ Res 100:1749–1754

    Article  CAS  PubMed  Google Scholar 

  41. Ribatti D, Nico B, Spinazzi R, Vacca A, Nussdorfer GG (2005) The role of adrenomedullin in angiogenesis. Peptides 26:1670–1675

    Article  CAS  PubMed  Google Scholar 

  42. Sakata J, Shimokubo T, Kitamura K, Nakamura S, Kangawa K, Matsuo H, Eto T (1993) Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Comm 195:921–927

    Article  CAS  PubMed  Google Scholar 

  43. Sato A, Canny BJ, Autelitano DJ (1997) Adrenomedullin stimulates cAMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocytes. Biochem Biophys Res Commun 230:311–314

    Article  CAS  PubMed  Google Scholar 

  44. Schulz R, Kelm M, Heusch G (2004) Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 61:402–413

    Article  CAS  PubMed  Google Scholar 

  45. Schulz R, Rassaf T, Massion PB, Kelm M, Balligand JL (2005) Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis. Pharmacol Ther 108:225–256

    Article  CAS  PubMed  Google Scholar 

  46. Shichiri M, Hirata Y (2003) Regulation of cell growth and apoptosis by adrenomedullin. Hypertens Res 26(Suppl):S9–S14

    Article  CAS  PubMed  Google Scholar 

  47. Shindo T, Kurihara Y, Nishimatsu H, Moriyama N, Kakoki M, Wang Y, Imai Y, Ebihara A, Kuwaki T, Ju KH, Minamino N, Kangawa K, Ishikawa T, Fukuda M, Akimoto Y, Kawakami H, Imai T, Morita H, Yazaki Y, Nagai R, Hirata Y, Kurihara H (2001) Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 104:1964–1971

    Article  CAS  PubMed  Google Scholar 

  48. Shiva S, Gladwin MT (2009) Nitrite mediates cytoprotection after ischemia/reperfusion by modulating mitochondrial function. Basic Res Cardiol 104:113–119

    Article  CAS  PubMed  Google Scholar 

  49. Webb A, Bond R, MacLean P, Uppal R, Benjamin N, Ahluwalia A (2004) Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad USA 101:13683–13688

    Article  CAS  Google Scholar 

  50. Yin H, Chao L, Chao J (2004) Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signalling. Hypertension 43:109–116

    Article  CAS  PubMed  Google Scholar 

  51. Zweier JL, Wang P, Samouilov A, Kappusamy P (1995) Enzyme-independent formation of nitric oxide in biological tissues. Nat Med 1:1103–1104

    Article  CAS  Google Scholar 

Download references

Acknowledgments

GFB and SAH acknowledge support for this work provided by the British Heart Foundation (PG/03/030). The work was also sponsored in part by the German DFG (RA969/4-1 to TR, and GRK1089/TP3 to TR, MT and CD).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gary F. Baxter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamid, S.A., Totzeck, M., Drexhage, C. et al. Nitric oxide/cGMP signalling mediates the cardioprotective action of adrenomedullin in reperfused myocardium. Basic Res Cardiol 105, 257–266 (2010). https://doi.org/10.1007/s00395-009-0058-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00395-009-0058-7

Keywords

Navigation